Heo Dae-Hyuk, Yang Min A, Song Jae Sun, Lee Won Dong, Cho Jin Woong
Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Korea.
Clin Endosc. 2024 Jul;57(4):495-500. doi: 10.5946/ce.2023.124. Epub 2024 Mar 29.
BACKGROUND/AIMS: Gastric subepithelial tumors (SETs) are often encountered during the upper gastrointestinal endoscopic screening. We assessed the prevalence of gastric SETs and the risk factors for their progression.
We reviewed the electronic medical records of 30,754 patients who underwent upper gastrointestinal endoscopic screening at our medical center between January 2013 and December 2016.
Among the 30,754 patients examined, 599 (1.94%) had gastric SETs. The prevalence increased with age and was 9.56% in patients aged ≥70 years. In total, 262 patients underwent serial endoscopy for more than 6 months. The median age was 68 years (interquartile range [IQR], 61-74), and the number of females was 167 (63.7%). During a median follow-up of 58 months (IQR, 38-75), 22 patients (8.4%) showed significant changes in tumor size. An irregular border (odds ratio, 4.623; 95% confidence interval, 1.093-19.558; p=0.037) was a significant risk factor for progression. Seven patients underwent surgical or endoscopic resections. The pathologies of gastric SETs included leiomyomas (n=3), gastrointestinal stromal tumors (n=2), and lipomas (n=2).
The prevalence of gastric SETs increases with age. Most gastric SETs do not progress during long-term endoscopic examinations, and the risk of an increase in size is low in asymptomatic small SETs without irregular borders.
背景/目的:胃黏膜下肿瘤(SETs)在上消化道内镜筛查中经常遇到。我们评估了胃SETs的患病率及其进展的危险因素。
我们回顾了2013年1月至2016年12月在我们医疗中心接受上消化道内镜筛查的30754例患者的电子病历。
在30754例接受检查的患者中,599例(1.94%)患有胃SETs。患病率随年龄增加而升高,≥70岁患者中患病率为9.56%。共有262例患者接受了超过6个月的连续内镜检查。中位年龄为68岁(四分位间距[IQR],61 - 74岁),女性患者167例(63.7%)。在中位随访58个月(IQR,38 - 75)期间,22例患者(8.4%)肿瘤大小出现显著变化。边界不规则(优势比,4.623;95%置信区间,1.093 - 19.558;p = 0.037)是进展的显著危险因素。7例患者接受了手术或内镜切除。胃SETs的病理类型包括平滑肌瘤(n = 3)、胃肠道间质瘤(n = 2)和脂肪瘤(n = 2)。
胃SETs的患病率随年龄增加而升高。大多数胃SETs在长期内镜检查期间不会进展,无症状且边界无不规则的小SETs大小增加的风险较低。